Diffuse Large B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Diffuse Large B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-12-10Clinical Trial Update: Rituximab-HyperCVAD (R-HCVAD) Alternating With Rituximab-Methotrexate-Cytarabine- (R-MC) in Newly Diagnosed Patients With Diffuse Large B-Cell Lymphoma With MYC-Rearrangement. [Phase 2]
This Phase 2 trial evaluating Rituximab-HyperCVAD alternating with Rituximab-Methotrexate-Cytarabine for newly diagnosed diffuse large B-cel…
-
CLINICAL_TRIALS withdrawal · 2013-08-26Clinical Trial Update: Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Se-Methyl-Seleno-L-Cysteine with Rituximab, Ifosfamide, Carboplatin, and Etoposide for relapsed or tre…
-
CLINICAL_TRIALS withdrawal · 2013-07-25Clinical Trial Update: Brentuximab Vedotin in CD30 Positive Epstein Barr Virus (EBV) Positive DLBCL of Elderly [NA]
A clinical trial evaluating Brentuximab vedotin for CD30-positive EBV-positive diffuse large B-cell lymphoma in elderly patients has been wi…
-
CLINICAL_TRIALS withdrawal · 2013-06-25Clinical Trial Update: GCS-100LE in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating GCS-100LE in combination with etoposide and dexamethasone for relapsed or refractory diffuse large B-cell lymph…